Free Trial

RAPT Therapeutics (RAPT) SEC Filings & 10K Form

RAPT Therapeutics logo
$1.13 +0.03 (+2.73%)
Closing price 04:00 PM Eastern
Extended Trading
$1.10 -0.02 (-2.21%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent RAPT Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
7:02 PM
RAPT Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:31 PM
RAPT Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:31 PM
RAPT Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:23 AM
FMR LLC (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
5:22 PM
RAPT Therapeutics (Issuer)
Wong Brian Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:23 PM
Brockstedt Dirk G. (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:24 PM
RAPT Therapeutics (Issuer)
Young Rodney KB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:26 PM
HO WILLIAM (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
6:35 AM
RAPT Therapeutics (Filer)
Form 424B3
01/27/2025
11:15 PM
RAPT Therapeutics (Filer)
Form EFFECT
01/21/2025
3:58 PM
RAPT Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/13/2025
3:17 PM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:38 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13G
01/06/2025
8:22 AM
Medicxi IV LP (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13G
01/06/2025
8:12 AM
Medicxi Co-Invest IV LP (Reporting)
Medicxi IV GP Ltd (Reporting)
Medicxi IV LP (Reporting)
Medicxi Ventures Management Ltd (0001715579) (Reporting)
RAPT Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2025
1:08 PM
RAPT Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/30/2024
2:32 PM
Foresite Capital Fund VI LP (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13G
12/23/2024
7:20 PM
COLUMN GROUP II, LP (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13D/A
12/23/2024
4:57 PM
Column Group II GP, LP (Reporting)
COLUMN GROUP II, LP (Reporting)
Column Group LLC (Reporting)
GOEDDEL DAVID V (Reporting)
Kutzkey Tim (Reporting)
Ponoi Capital II, LP (Reporting)
PONOI CAPITAL, LP (Reporting)
Ponoi II Management, LLC (Reporting)
Ponoi Management, LLC (Reporting)
RAPT Therapeutics (Issuer)
Svennilson Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:59 PM
COLUMN GROUP II, LP (Reporting)
Column Group IV GP, LP (Reporting)
Column Group IV, LP (Reporting)
Column Group IV-A, LP (Reporting)
RAPT Therapeutics (Issuer)
TCG IV GP, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:55 PM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:42 PM
Deep Track Capital, LP (Filed by)
RAPT Therapeutics (Subject)
Form SCHEDULE 13G
12/23/2024
6:16 AM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:00 PM
Brockstedt Dirk G. (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
HO WILLIAM (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
RAPT Therapeutics (Issuer)
Wong Brian Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
RAPT Therapeutics (Issuer)
Young Rodney KB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:15 PM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:39 AM
Deep Track Capital, LP (Filed by)
RAPT Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:59 PM
RAPT Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
RAPT Therapeutics (Subject)
Form SC 13G/A
11/04/2024
12:30 PM
RAPT Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/08/2024
7:05 AM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:10 AM
RAPT Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:24 PM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
5:10 PM
Giordano Michael F (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:13 PM
GRAY MARY ANN (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:14 PM
Kozick Linda (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:16 PM
Lyons-Williams Lori (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:18 PM
RAPT Therapeutics (Issuer)
RIEFLIN WILLIAM JL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:19 PM
RAPT Therapeutics (Issuer)
Robbins Wendye (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Musk Wants to Audit Fort Knox—What It Means for Your Retirement (Ad)

You can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FREE. All you need is to know these 2 "magic words" only revealed inside your FREE copy of this 2025 Gold Guide.

Tap the link to get your free 2025 Gold Guide now
05/23/2024
3:49 PM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:03 AM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
7:08 AM
RAPT Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/05/2024
3:11 PM
RAPT Therapeutics (Filer)
Form ARS
04/01/2024
5:48 PM
RAPT Therapeutics (Issuer)
RIEFLIN WILLIAM JL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:51 PM
GRAY MARY ANN (Reporting)
RAPT Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:53 PM
RAPT Therapeutics (Issuer)
Robbins Wendye (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
7:03 AM
RAPT Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:08 AM
RAPT Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RAPT) was last updated on 3/5/2025 by MarketBeat.com Staff
From Our Partners